For parents of a child newly diagnosed with a bleeding disorder, medical costs and insurance coverage instantly become big concerns because of the high cost of clotting factor.
The journal Science has published two papers online that it says cast doubt on the link between XMRV and chronic fatigue syndrome (CFS) and has asked study authors to voluntarily retract their 2009 paper linking XMRV and CFS.
